Hypertrophic cardiomyopathy: Value of atrial programmed electrical stimulation in patients with or without syncope with special reference to the role of atrial arrhythmias

International Journal of Cardiology

Volumn 59, Issue 1, 1997, Pages 47-56

  Brembilla Perrot, Béatrice ^a   Jacquot, Alain ^a   Beurrier, Daniel ^a   Jacquemin, Laurent ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

Atrial fibrillation; Hypertrophic cardiomyopathy; Programmed atrial stimulation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DISOPYRAMIDE; NADOLOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; ELECTROCARDIOGRAM; ELECTROSTIMULATION; FEMALE; FOLLOW UP; HEART ATRIUM ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINUS RHYTHM; SYNCOPE;

ADULT; AGED; ATRIAL FIBRILLATION; CARDIOMYOPATHY, HYPERTROPHIC; ELECTRIC STIMULATION; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SYNCOPE; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 0030888208     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(96)02900-2     Document Type: Article

References (37)

1. McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical electrocardiographic and hemodynamic features. Am J Cardiol 1981;47:532-538.
2. Fananapazir L, Tracy CM, Leon ML, Cannon III RO, Bonow RO, Maron BJ, Epstein SE. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation 1989;80:1259-1268.
3. Nienaber CA, Hiller S, Spielmann RP, Geiger M, Kuck KH. Syncope in hypertrophic cardiomyopathy: multivariate analysis of prognostic determinants. J Am Coll Cardiol 1990;15:948-955.
4. Gilligan DM, Nihoyannopoulos P, Chan WL, Oakley CM. Investigation of a hemodynamic basis for syncope in hypertrophic cardiomyopathy. Use of a head up tilt test. Circulation 1992;85:2140-2148.
5. Greenspan AM. Hypertrophic cardiomyopathy and atrial fibrillation: a change of perspective (editorial comment). J Am Coll Cardiol 1990;15:1286-1287.
6. Watson RM, Schwartz JL, Maron BJ, Tucker E, Rosing DR, Josephson ME. Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death. J Am Coll Cardiol 1987;10:761-774.
7. Kowey PR, Eisenberg R, Engel TR. Sustained arrhythmias in hypertrophic obstructive cardiomyopathy. New Engl J Med 1984;310:1561-1566.
8. Koga Y, Itaya KI, Toshima H. Prognosis in hypertrophic cardiomyopathy. Am Heart J 1984;108:351-359.
9. Fananapazir L, Chang AC, Epstein SE, McAreavey D. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic and electrophysiological findings. Circulation 1992;86:730-740.
10. Brembilla-Perrot B, Terrier de la Chaise A, Lessa de Souza M, Bailly L. Incidence and significance of inducible supraventricular tachyarrhythmias in patients with chronic myocardial infarction. Eur Heart J 1991;12:401-404.
11. Brembilla-Perrot B, Donetti J, Terrier de la Chaise A, Sadoul N, Aliot E, Juillière Y. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. Am Heart J 1991;121:1124-1131.
12. Brembilla-Perrot B, Terrier de la Chaise A, Pichené M, Aliot E, Cherrier F, Pernot C. Isoprenaline as an aid to the induction of catecholamine dependent supraventricular tachychycardias during programmed stimulation. Br Heart J 1989;61:348-355.
13. Brembilla-Perrot B, Terrier de la Chaise A. Lack of prognostic implications of spontaneously occurring or stimulation induced atrial tachyarrhythmias in patients with dilated cardiomyopathy. Eur Heart J 1992;13:483-477.
14. Fananapazir L, Cannon RO, Tripodi D, Panza JM. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and β-adrenergic blocker therapy. Circulation 1992;85:2149-2161.
15. Cosio FG, Paylos J, Requena M, Fernandez-Yanez J. Influence of basic atrial rhythm on intraatrial conduction of extrastimuli. Am J Cardiol 1984;53:1018-1021.
16. Wyndham CRC, Amat Y Leon F, Wu D, Denes P, Dhingra R, Simpson R, Rosen KM. Effects of cycle length on atrial vulnerability. Circulation 1977;55:260-267.
17. Niwano S, Aizawa Y Fragmented atrial activity in patients with transient atrial fibrillation. Am Heart J 1991;121:62-67.
18. Savage DD, Seides SF, Maron BJ, Myers DJ, Epstein SE. Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and non-obstructive hypertrophic cardiomyopathy. Circulation 1979;59:866-875.
19. Frank MJ, Watkins LO, Prisant M, Stefadouros MA, Abdulla AM. Rhythm disturbances in hypertrophic cardiomyopathies: relationship to symptoms and the effect of 'complete' blockade. Eur Heart J 1983;4:235-243.
20. Lazzeroni E, Domenicucci S, Finardi A, Zoni A, Dodi C, Francescon D, Botti P. Severity of arrhythmias and extent of hypertrophy in hypertrophic cardiomyopathy. Am Heart J 1989;118:73-78.
21. Robinson K, Frenneaux MP, Stockins B. Atrial fibrillation in hypertrophic cardiomyopathy:a longitudinal study. J Am Coll Cardiol 1990;15:1279-1285.
22. Mc Kenna WJ, England D, Doi YL, Deanfield JE, Oakley C, Goodwin JF. Arrhythmia in hypertrophic cardiomyopathy: influence on prognosis. Br Heart J 1981;46:168-172.
23. Spirito P, Lakatos E, Maron BJ. Degree of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy and chronic atrial fibrillation. Am J Cardiol 1992;69:1217-1222.
24. Glancy DL, O'Brien KP, Gold HK, Epstein SE. Atrial fibrillation in patients with idiopathic hypertrophic sub aortic stenosis. Br Heart J 1970;32:652-659.
25. McKenna WJ, Krikler DM, Goodwin JF. Arrhythmias in dilated and hypertrophic cardiomyopathy. Med Clin North Am 1984;68:983-999.
26. Wigle ED, Sasson Z., Henderson MA, Ruddy TD, Fulop J, Rakoswski H., Williams WG. Hypertrophic cardiomyopathy. The importance of the site and extent of hypertrophy. A review. Prog Cardiovasc Dis 1985;28:10-83.
27. Madariaga I, Carmona JR, Mateas FR, Lezaun R, De Los Arcos E. Supraventricular arrhythmia as the cause of sudden death in hypertrophic cardiomyopathy. Eur Heart J 1994;15:134-137.
28. Stafford WJ, Throhman RG, Bilsker M, Zaman L, Castellanos A, Myerburg RJ. Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;7:701-704.
29. Krikler DM, Davies MJ, Rowland E, Goodwin Jf, Evans RC, Shaw DB. Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. Br Heart J 1980;43:245-251.
30. Brandenburg RO. Syncope and sudden death in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990;15:962-964.
31. Kuck KH, Kunze KP, Schluter M, Nienaber CA, Costard A. Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope. Eur Heart J 1988;9:177-185.
32. Leitch JW, Klein GJ, Yee R, Leather RA, Kim YH. Syncope associated with supraventricular tachycardia. An expression of tachycardia rate or vasomotor response? Circulation 1992;85:1064-1071.
33. McKenna WJ, Oakley CM, Krikler DM, Goodwin JC. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J 1985;53:412-416.
34. Pollick C, Kimball B, Henderson M, Wigle D. Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration. Am J Cardiol 1988;62:1248-1251.
35. Kimball BP, Bui S, Wigle ED. Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy. Am Heart J 1993;125:1691-1697.
36. Epstein SE, Rosing DR. Verapamil: its potential for causing serious complications in patients with hypertrohic cardiomyopathy. Circulation 1981;64:437-442.
37. Fananapazir L, Epstein SE. Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone. Am J Car-diol 1991;67:175-182.